Clinical Trials
3 trialsNCT03423199 2024-03-22
PATHWAY
National Cancer Center, Japan
Phase 3 Unknown
NCT05429684 2022-06-23
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase 3 Unknown
NCT04047758 2021-07-20
Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer
Shengjing Hospital
Phase 3 Unknown